FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4320919557> ?p ?o ?g. }

• W4320919557 endingPage "641" @default.
• W4320919557 startingPage "641" @default.
• W4320919557 abstract "The present study delineates the preparation of piperine-loaded spanlastics (PIP-SPL) to improve piperine (PIP) solubility, bioavailability, and permeation through nasal mucosa for intranasal delivery. PIP-SPL was formulated using the thin-film hydration method and optimization was performed using Box-Behnken design (BBD). PIP-SPL optimized formulation (PIP-SPLopt) was characterized for polydispersity index (PDI), vesicle size, entrapment efficiency, zeta potential, and in vitro PIP release. For further evaluation, blood-brain distribution study, transmission electron microscopy (TEM), nasal permeation study, and confocal scanning laser microscopy (CLSM) were performed withal. The PIP-SPLopt presented spherical and sealed shape vesicles with a small vesicle size of 152.4 nm, entrapment efficiency of 72.93%, PDI of 0.1118, and in vitro release of 82.32%. The CLSM study unveiled that the developed formulation has greater permeation of PIP across the nasal mucosa in comparison with the PIP suspension. The blood-brain distribution study demonstrated higher Cmax and AUC0-24h of PIP-SPL via the intranasal route in comparison to PIP-SPL via oral administration. The in vivo study revealed that the PIP-SPL has good antiepileptic potential in comparison with the standard diazepam, which was evinced by seizure activity, neuromuscular coordination by rotarod test, biochemical estimation of oxidative stress markers, and histopathological studies. Furthermore, nasal toxicity study confirm that the developed PIP-SPL formulation is safer for intranasal application. The current investigation corroborated that the prepared spanlastic vesicle formulation is a treasured carrier for the PIP intranasal delivery for the management of epilepsy." @default.
• W4320919557 created "2023-02-16" @default.
• W4320919557 creator A5014615503 @default.
• W4320919557 creator A5015919296 @default.
• W4320919557 creator A5030693714 @default.
• W4320919557 creator A5036387641 @default.
• W4320919557 creator A5085410281 @default.
• W4320919557 creator A5089261501 @default.
• W4320919557 date "2023-02-14" @default.
• W4320919557 modified "2023-10-12" @default.
• W4320919557 title "Spanlastics as a Potential Approach for Enhancing the Nose-To-Brain Delivery of Piperine: In Vitro Prospect and In Vivo Therapeutic Efficacy for the Management of Epilepsy" @default.
• W4320919557 cites W1975440733 @default.
• W4320919557 cites W2089543245 @default.
• W4320919557 cites W2125514183 @default.
• W4320919557 cites W2535663959 @default.
• W4320919557 cites W2754524371 @default.
• W4320919557 cites W2755976807 @default.
• W4320919557 cites W2775629423 @default.
• W4320919557 cites W2901682025 @default.
• W4320919557 cites W2957083681 @default.
• W4320919557 cites W2963457415 @default.
• W4320919557 cites W3011995060 @default.
• W4320919557 cites W3042836528 @default.
• W4320919557 cites W3084527332 @default.
• W4320919557 cites W3097841280 @default.
• W4320919557 cites W3164889345 @default.
• W4320919557 cites W3170995540 @default.
• W4320919557 cites W3201587056 @default.
• W4320919557 cites W4224277388 @default.
• W4320919557 cites W4229363607 @default.
• W4320919557 cites W4283778659 @default.
• W4320919557 cites W4291782623 @default.
• W4320919557 cites W4295753288 @default.
• W4320919557 cites W4307103205 @default.
• W4320919557 cites W4308247447 @default.
• W4320919557 cites W4310211180 @default.
• W4320919557 cites W4313321637 @default.
• W4320919557 cites W4313321667 @default.
• W4320919557 cites W4313677377 @default.
• W4320919557 doi "https://doi.org/10.3390/pharmaceutics15020641" @default.
• W4320919557 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36839963" @default.
• W4320919557 hasPublicationYear "2023" @default.
• W4320919557 type Work @default.
• W4320919557 citedByCount "8" @default.
• W4320919557 countsByYear W43209195572023 @default.
• W4320919557 crossrefType "journal-article" @default.
• W4320919557 hasAuthorship W4320919557A5014615503 @default.
• W4320919557 hasAuthorship W4320919557A5015919296 @default.
• W4320919557 hasAuthorship W4320919557A5030693714 @default.
• W4320919557 hasAuthorship W4320919557A5036387641 @default.
• W4320919557 hasAuthorship W4320919557A5085410281 @default.
• W4320919557 hasAuthorship W4320919557A5089261501 @default.
• W4320919557 hasBestOaLocation W43209195571 @default.
• W4320919557 hasConcept C136229726 @default.
• W4320919557 hasConcept C150903083 @default.
• W4320919557 hasConcept C181389837 @default.
• W4320919557 hasConcept C185592680 @default.
• W4320919557 hasConcept C203014093 @default.
• W4320919557 hasConcept C207001950 @default.
• W4320919557 hasConcept C2780133158 @default.
• W4320919557 hasConcept C41625074 @default.
• W4320919557 hasConcept C50670333 @default.
• W4320919557 hasConcept C55493867 @default.
• W4320919557 hasConcept C59377437 @default.
• W4320919557 hasConcept C71924100 @default.
• W4320919557 hasConcept C85663871 @default.
• W4320919557 hasConcept C86803240 @default.
• W4320919557 hasConcept C98274493 @default.
• W4320919557 hasConceptScore W4320919557C136229726 @default.
• W4320919557 hasConceptScore W4320919557C150903083 @default.
• W4320919557 hasConceptScore W4320919557C181389837 @default.
• W4320919557 hasConceptScore W4320919557C185592680 @default.
• W4320919557 hasConceptScore W4320919557C203014093 @default.
• W4320919557 hasConceptScore W4320919557C207001950 @default.
• W4320919557 hasConceptScore W4320919557C2780133158 @default.
• W4320919557 hasConceptScore W4320919557C41625074 @default.
• W4320919557 hasConceptScore W4320919557C50670333 @default.
• W4320919557 hasConceptScore W4320919557C55493867 @default.
• W4320919557 hasConceptScore W4320919557C59377437 @default.
• W4320919557 hasConceptScore W4320919557C71924100 @default.
• W4320919557 hasConceptScore W4320919557C85663871 @default.
• W4320919557 hasConceptScore W4320919557C86803240 @default.
• W4320919557 hasConceptScore W4320919557C98274493 @default.
• W4320919557 hasIssue "2" @default.
• W4320919557 hasLocation W43209195571 @default.
• W4320919557 hasLocation W43209195572 @default.
• W4320919557 hasLocation W43209195573 @default.
• W4320919557 hasOpenAccess W4320919557 @default.
• W4320919557 hasPrimaryLocation W43209195571 @default.
• W4320919557 hasRelatedWork W1518689421 @default.
• W4320919557 hasRelatedWork W2065609057 @default.
• W4320919557 hasRelatedWork W2090283026 @default.
• W4320919557 hasRelatedWork W2092032160 @default.
• W4320919557 hasRelatedWork W2549423177 @default.
• W4320919557 hasRelatedWork W2890753467 @default.
• W4320919557 hasRelatedWork W2894130453 @default.
• W4320919557 hasRelatedWork W3006293769 @default.
• W4320919557 hasRelatedWork W3081545856 @default.

• next